Brain, Vol. 111, No. 3, 577-596, 1988
© 1988 Guarantors of Brain
research-article |
THE LAMBERT-EATON MYASTHENIC SYNDROME
A REVIEW OF 50 CASES
From the The National Hospital for Nervous Diseases Queen Square Department of Neurological Science, Royal Free Hospital School of Medicine London
Correspondence to:
Correspondence to: Professor J. Newsom-Davis, Department of Clinical Neurology, University of Oxford, Radcliffe Infirmary, Oxford OX2 6HE.
The clinical and electrophysiological features of 50 consecutive patients with the Lambert-Eaton myasthenic syndrome (LEMS) have been analysed. Carcinoma was detected (CD group) in 25, of whom 21 had small cell lung cancer (SCLC). SCLC was evident within 2 yrs of onset of LEMS symptoms in 20/21 cases, and at 3.8 yrs in 1/21. In the cases in whom no carcinoma was detected (NCD group), 14/25 had a history of LEMS > 5 yrs. The dominant neurological features were similar in the CD and NCD groups, and consisted of proximal lower limb weakness (100%), depressed tendon reflexes (92%) with posttetanic potentiation (78%), autonomic features, especially dryness of the mouth (74%) and mild/moderate ptosis (54%). The compound evoked muscle action potential amplitude in abductor digiti minimi was below the lower limit of control values in 48/50, and the increment following maximum voluntary contraction above the upper limit of control values in 48/50. Single fibre electromyographic abnormalities were found in 29/29 cases.
The analysis indicates that a patient presenting with LEMS has a 62% risk of an underlying SCLC, and that this risk declines sharply after 2 yrs, becoming very low at 4 to 5 yrs. It is argued that in SCLC cases antigenic determinants on tumour cells initiate the autoimmune response, often early in the course of the malignancy, but that the association of LEMS with tumours other than SCLC may be fortuitous. In the latter, and in NCD patients, the initiating factor(s) are unknown.
Received July 14, 1987. Accepted September 11, 1987.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. Lang and A. Evoli SOX1 autoantibodies: Tumor markers in LEMS patients? Neurology, March 18, 2008; 70(12): 906 - 907. [Full Text] [PDF]
|
|
|
|
|
|
L. Sabater, M. Titulaer, A. Saiz, J. Verschuuren, A. O. Gure, and F. Graus SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome Neurology, March 18, 2008; 70(12): 924 - 928. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. P. Hirsch Neuromuscular junction in health and disease Br. J. Anaesth., July 1, 2007; 99(1): 132 - 138. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. de Beukelaar and P. A. S. Smitt Managing paraneoplastic neurological disorders. Oncologist, March 1, 2006; 11(3): 292 - 305. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N.M. Warren, M. Bennett, M. Lai, J. Forty, and T.J. Walls Lambert-Eaton myasthenic syndrome associated with thymitis Neurology, January 11, 2005; 64(1): 168 - 169. [Full Text] [PDF]
|
|
|
|
 |
|
 S Payne, D Wilkins, and R Howard An unusual cause of dysphagia J. Neurol. Neurosurg. Psychiatry, January 1, 2005; 76(1): 146 - 146. [Full Text] [PDF]
|
|
|
|
|
|
F Graus, J Y Delattre, J C Antoine, J Dalmau, B Giometto, W Grisold, J Honnorat, P S. Smitt, C. Vedeler, J J G M Verschuuren, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes J. Neurol. Neurosurg. Psychiatry, August 1, 2004; 75(8): 1135 - 1140. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. W. Wirtz, J. G. van Dijk, P. A. van Doorn, B. G.M. van Engelen, A. J. van der Kooi, J. B. Kuks, A. Twijnstra, M. de Visser, L. H. Visser, J. H. Wokke, et al. The epidemiology of the Lambert-Eaton myasthenic syndrome in the Netherlands Neurology, July 27, 2004; 63(2): 397 - 398. [Full Text] [PDF]
|
|
|
|
|
|
Y.K. Nakao, M. Motomura, T. Fukudome, T. Fukuda, H. Shiraishi, T. Yoshimura, M. Tsujihata, and K. Eguchi Seronegative Lambert-Eaton myasthenic syndrome: Study of 110 Japanese patients Neurology, December 10, 2002; 59(11): 1773 - 1775. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P W Wirtz, M Sotodeh, M Nijnuis, P A van Doorn, B G M van Engelen, R Q Hintzen, P L M de Kort, J B Kuks, A Twijnstra, M de Visser, et al. Difference in distribution of muscle weakness between myasthenia gravis and the Lambert-Eaton myasthenic syndrome J. Neurol. Neurosurg. Psychiatry, December 1, 2002; 73(6): 766 - 768. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Odabasi, M. Demirci, D.S. Kim, D.K. Lee, H.F. Ryan, G.C. Claussen, A. Tseng, and S.J. Oh Postexercise facilitation of reflexes is not common in Lambert-Eaton myasthenic syndrome Neurology, October 8, 2002; 59(7): 1085 - 1087. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. K. Hart, P. Maddison, J. Newsom-Davis, A. Vincent, and K. R. Mills Phenotypic variants of autoimmune peripheral nerve hyperexcitability Brain, August 1, 2002; 125(8): 1887 - 1895. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-Y. Tsao, J. R. Mendell, M. L. Friemer, and J. T. Kissel Lambert-Eaton Myasthenic Syndrome in Children J Child Neurol, January 1, 2002; 17(1): 74 - 76. [Abstract] [PDF]
|
|
|
|
 |
|
 B. M. Leonovicz, E. A. Gordon, and C. T. Wass Paraneoplastic Syndromes Associated with Lung Cancer: A Unique Case of Concomitant Subacute Cerebellar Degeneration and Lambert-Eaton Myasthenic Syndrome Anesth. Analg., December 1, 2001; 93(6): 1557 - 1559. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Graus, F. Keime-Guibert, R. Rene, B. Benyahia, T. Ribalta, C. Ascaso, G. Escaramis, and J. Y. Delattre Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients Brain, June 1, 2001; 124(6): 1138 - 1148. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Oyaizu, Y. Okada, M. Sagawa, K. Yamakawa, H. Kuroda, K. Fujihara, Y. Itoyama, T. Tanita, M. Motomura, and T. Kondo Lambert-Eaton myasthenic syndrome associated with an anterior mediastinal small cell carcinoma J. Thorac. Cardiovasc. Surg., May 1, 2001; 121(5): 1005 - 1006. [Full Text] [PDF]
|
|
|
|
 |
|
 M Abu-Shakra, D Buskila, M Ehrenfeld, K Conrad, and Y Shoenfeld Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies Ann Rheum Dis, May 1, 2001; 60(5): 433 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P Maddison, B Lang, K Mills, and J Newsom-Davis Long term outcome in Lambert-Eaton myasthenic syndrome without lung cancer J. Neurol. Neurosurg. Psychiatry, February 1, 2001; 70(2): 212 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Gao, Y. Sekido, A. Maximov, M. Saad, E. Forgacs, F. Latif, M. H. Wei, M. Lerman, J.-H. Lee, E. Perez-Reyes, et al. Functional Properties of a New Voltage-dependent Calcium Channel alpha 2delta Auxiliary Subunit Gene (CACNA2D2) J. Biol. Chem., April 14, 2000; 275(16): 12237 - 12242. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Iwasa, M. Takamori, K. Komai, and Y. Mori Recombinant calcium channel is recognized by Lambert-Eaton myasthenic syndrome antibodies Neurology, February 8, 2000; 54(3): 757 - 757. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. A. Zifko, M. W. Nicolle, W. Grisold, and C. F. Bolton Repetitive phrenic nerve stimulation in myasthenia gravis Neurology, September 1, 1999; 53(5): 1083 - 1083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Seneviratne and R. de Silva Classic diseases revisited: Lambert-Eaton myasthenic syndrome Postgrad. Med. J., September 1, 1999; 75(887): 516 - 520. [Abstract] [Full Text]
|
|
|
|
|
|
J.-C. Antoine, J.-F. Mosnier, L. Absi, P. Convers, J. Honnorat, and D. Michel Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without anti-onconeural antibodies J. Neurol. Neurosurg. Psychiatry, July 1, 1999; 67(1): 7 - 14. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. O. Dalmau and J. B. Posner Neurological Paraneoplastic Syndromes Neuroscientist, November 1, 1998; 4(6): 443 - 453. [PDF]
|
|
|
|
|
|
P. Maddison, J. Newsom-Davis, and K. R Mills Distribution of electrophysiological abnormality in Lambert-Eaton myasthenic syndrome J. Neurol. Neurosurg. Psychiatry, August 1, 1998; 65(2): 213 - 217. [Abstract] [Full Text]
|
|
|
|
|
|
C. GALTON, D. THOMSON, and R. BOYLE Lambert-Eaton myasthenic syndrome and non-pulmonary small cell carcinoma J. Neurol. Neurosurg. Psychiatry, June 1, 1998; 64(6): 819 - 820. [Full Text]
|
|
|
|
|
|
T. Iwahashi, A. Inoue, C.-S. Koh, and N. Yanagisawa A study on a new antineural antibody in a case of paraneoplastic sensory neuropathy associated with breast carcinoma J. Neurol. Neurosurg. Psychiatry, October 1, 1997; 63(4): 516 - 519. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Weinberg and E. J. Mark Case 32-1994- A 61-Year-Old Man with Muscular Weakness N. Engl. J. Med., August 25, 1994; 331(8): 528 - 535. [Full Text]
|
|
|
|
|
|
R. Freeman and D. N. Louis Case 29-1994- A 32-Year-Old Man with Exercise-Induced Hyperthermia and Acquired Anhidrosis N. Engl. J. Med., July 28, 1994; 331(4): 259 - 265. [Full Text]
|
|
|
|
|
|
T. J. Lynch and N. L. Harris Case 27-1994- A 41-Year-Old Woman with Neurologic Abnormalities and an Osteolytic Lesion in the Mandible N. Engl. J. Med., July 14, 1994; 331(2): 107 - 113. [Full Text]
|
|
|
|
 |
|
 G. Erlington Review paper: The Lambert-Eaton myasthenic syndrome Palliative Medicine, January 1, 1992; 6(1): 9 - 17. [Abstract] [PDF]
|
|